Activist 13D/13G Filings - OCULIS HLDG AG NAMEN AKT (OCS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-13
4:01 pm
Sale
13GOCULIS HLDG AG NAMEN AKT
OCS
Novartis Bioventures Ltd1,713,521
4.700%
-464,381decrease
(-21.32%)
View
2024-02-12
9:06 pm
Sale
13GOCULIS HLDG AG NAMEN AKT
OCS
Pivotal bioVenture Partners Fund I L.P.2,414,972
7.400%
-617,324decrease
(-20.36%)
View
2024-02-09
06:47 am
Purchase
13GOCULIS HLDG AG NAMEN AKT
OCS
LSP 7 Cooperative UA5,327,362
14.600%
5,327,362increase
(New Position)
View
2023-05-04
4:05 pm
Purchase
13GOCULIS HLDG AG NAMEN AKT
OCS
Brunnur vaxtarsjodur slhf2,335,841
7.100%
2,335,841increase
(New Position)
View
2023-05-02
06:06 am
Purchase
13GOCULIS HLDG AG NAMEN AKT
OCS
BVCF IV L.P.2,070,020
6.230%
2,070,020increase
(New Position)
View
2023-03-15
12:53 pm
Purchase
13GOCULIS HLDG AG NAMEN AKT
OCS
Pivotal bioVenture Partners Fund I L.P.3,032,296
9.300%
3,032,296increase
(New Position)
View
2023-03-13
08:01 am
Purchase
13GOCULIS HLDG AG NAMEN AKT
OCS
Novartis Bioventures Ltd2,177,902
6.700%
2,177,902increase
(New Position)
View